DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Park YH, Kim TY, Kim GM. et al.
A randomized phase II study of palbociclib plus exemestane with GnRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer (KCSG‑BR 15-10, NCT02592746).
J Clin Oncol 2019;
37: Abstr. 1007
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.